Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$13.46
+1.9%		$15.82
$8.70
▼
$20.49
$1.05B1.21903,125 shs362,037 shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$161.43
-1.0%		$167.57
$113.37
▼
$192.85
$4.03B0.86282,605 shs91,174 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$16.38
+0.9%		$18.96
$12.26
▼
$29.65
$1.14B1.662.11 million shs735,807 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
0.00%-1.71%-13.21%-30.07%-12.40%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.00%+1.67%+6.77%+3.59%+37.59%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
0.00%+0.81%-3.73%-10.28%+9.80%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$13.46
+1.9%		$15.82
$8.70
▼
$20.49
$1.05B1.21903,125 shs362,037 shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$161.43
-1.0%		$167.57
$113.37
▼
$192.85
$4.03B0.86282,605 shs91,174 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$16.38
+0.9%		$18.96
$12.26
▼
$29.65
$1.14B1.662.11 million shs735,807 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
0.00%-1.71%-13.21%-30.07%-12.40%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.00%+1.67%+6.77%+3.59%+37.59%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
0.00%+0.81%-3.73%-10.28%+9.80%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
1.88
Reduce$16.7124.14% Upside
ICU Medical, Inc. stock logo
ICUI
ICU Medical
2.89
Moderate Buy$192.8019.43% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.43
Hold$27.0865.30% Upside

Current Analyst Ratings Breakdown

Latest ICUI, TNDM, and IART Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/14/2026
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetHold$19.00 ➝ $15.00
10/13/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$18.00
10/8/2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold (C-) ➝ Hold (C)
10/7/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold
10/6/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access to unlock brokerage rankings
Initiated CoverageOverweight ➝ Positive$18.00
10/5/2026
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingNeutral$19.00 ➝ $15.00
10/5/2026
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetMarket Perform$18.00 ➝ $15.00
10/3/2026
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$15.00
10/2/2026
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D-) ➝ Sell (E+)
10/1/2026
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold
9/30/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetNeutral$24.00 ➝ $20.00
(Data available from 10/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$1.64B0.64$4.30 per share3.13$13.40 per share1.00
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.16B1.87$14.44 per share11.18$86.03 per share1.88
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$1.04B1.09N/AN/A$2.29 per share7.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
-$516.47M-$0.09N/A5.450.70-0.44%18.30%5.30%10/21/2026 (Estimated)
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$730K$1.18136.8020.052.051.39%7.91%4.17%11/5/2026 (Estimated)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$204.71M-$0.93N/A182.02N/A-6.08%-45.97%-6.23%11/5/2026 (Estimated)

Latest ICUI, TNDM, and IART Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.14N/AN/AN/A$552.07 millionN/A
11/5/2026Q3 2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.2451N/AN/AN/A$265.84 millionN/A
10/21/2026Q3 2026
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$0.5630N/AN/AN/A$413.16 millionN/A
8/6/2026Q2 2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$1.91$2.37+$0.46$0.76$533.44 million$547.88 million
8/6/2026Q2 2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.3207-$0.31+$0.0107-$0.31$254.99 million$254.56 million
7/29/2026Q2 2026
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$0.4805$0.56+$0.0795$0.06$417.54 million$418.76 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
1.75
3.60
2.11
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.56
2.43
1.21
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
4.62
3.18
2.65

Institutional Ownership

CompanyInstitutional Ownership
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
84.78%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
3.84%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
2.10%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
4,42777.77 million74.79 millionOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
13,00024.99 million24.47 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,50069.58 million68.12 millionOptionable

Recent News About These Companies

Tandem Diabetes Care (NASDAQ:TNDM) Shares Climb 4% - Time to Buy?
October 18 at 4:21 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31131078
Tandem Diabetes Care (TNDM) Following App Recall Is The Undervalued Case Still Intact
October 18 at 3:45 AM  |  cedarnews.netC
Tandem Diabetes Care (NASDAQ:TNDM) Stock Jumps 4% - Here's Why
October 16 at 1:59 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tandem-diabetes-care-nasdaq-tndm-stock-jumps-4-heres-why-2026-10-16/
Tandem Diabetes Care (NASDAQ:TNDM) Sees Large Volume Increase - Should You Buy?
October 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tandem-diabetes-care-nasdaq-tndm-sees-large-volume-increase-should-you-buy-2026-10-15/
Tandem Diabetes Care (NASDAQ:TNDM) Stock Bought by Rep. Gilbert Ray Cisneros, Jr.
October 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/congress-tandem-diabetes-care-nasdaq-tndm-stock-bought-by-rep-gilbert-ray-cisneros-jr-2026-10-14/
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock Now Rated "Hold" by Wall Street Brokerages
October 13, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31113607
Tandem Diabetes Care, Inc. (TNDM) - What Are Researchers Thinking About This Stock?
October 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-tandem-diabetes-care-inc-tndm-what-are-researchers-thinking-about-this-stock-2026-10-13/
Barclays Keeps Their Hold Rating on Tandem Diabetes Care (TNDM)
October 12, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TNDM/pressreleases/5046970/barclays-keeps-their-hold-rating-on-tandem-diabetes-care-tndm/
Is it the Right Time to Hold TNDM Stock in Your Portfolio?
October 9, 2026  |  zacks.comhttps://www.zacks.com/stock/news/3003781/is-it-the-right-time-to-hold-tndm-stock-in-your-portfolio?cid=cs-stocknewsapi-ft-analyst_blog|rank_focused-3003781
Tandem Diabetes Care (NASDAQ:TNDM) Stock Rating Upgraded by Barclays
October 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31099296
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded at Barclays
October 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-tandem-diabetes-care-nasdaq-tndm-upgraded-at-barclays-2026-10-08/
Barclays Starts Tandem Diabetes Care (TNDM) at Equalweight
October 7, 2026  |  streetinsider.comhttps://www.streetinsider.com/New+Coverage/Barclays+Starts+Tandem+Diabetes+Care+%28TNDM%29+at+Equalweight/27155866.html
Barclays initiates coverage of Tandem Diabetes Care at equal-weight
October 7, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/barclays-initiates-coverage-of-tandem-diabetes-care-at-equal-weight/ar-AA2dLrGx
Tandem Diabetes Care stock gains 2.36 percent before Q3 results
October 5, 2026  |  ad-hoc-news.deA
Tandem Diabetes Care (TNDM) Receives a Buy from RBC Capital
October 5, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TNDM/pressreleases/4947000/tandem-diabetes-care-tndm-receives-a-buy-from-rbc-capital/
Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026
October 1, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tandem-diabetes-care-announce-third-200500857.html
Tandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump System
October 1, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tandem-diabetes-care-tndm-7-012256615.html
Citigroup Issues Pessimistic Forecast for Tandem Diabetes Care (NASDAQ:TNDM) Stock Price
September 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-citigroup-issues-pessimistic-forecast-for-tandem-diabetes-care-nasdaq-tndm-stock-price-2026-09-30/
Tandem Diabetes Expands Insulin Delivery System to 12 New Countries
September 28, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tandem-diabetes-expands-insulin-delivery-094359106.html
Tandem Diabetes Care, Inc. Announces Tandem Mobi Automated Insulin Delivery System Is Now Available in Twelve International Markets
September 28, 2026  |  marketscreener.comM
Tandem Diabetes expands Mobi insulin system overseas
September 28, 2026  |  grafa.comG

New MarketBeat Followers Over Time

Media Sentiment Over Time

Integra LifeSciences stock logo

Integra LifeSciences NASDAQ:IART

$13.46 +0.25 (+1.92%)
As of 03:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

ICU Medical stock logo

ICU Medical NASDAQ:ICUI

$161.43 -1.56 (-0.96%)
As of 03:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Tandem Diabetes Care stock logo

Tandem Diabetes Care NASDAQ:TNDM

$16.38 +0.14 (+0.87%)
As of 03:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas